• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

因长期物质滥用导致的身体伤害。

Physical harm due to chronic substance use.

机构信息

National Institute of Public Health and the Environment (RIVM), Centre for Health Protection, P.O. Box 1, 3720 BA Bilthoven, The Netherlands.

出版信息

Regul Toxicol Pharmacol. 2013 Jun;66(1):83-7. doi: 10.1016/j.yrtph.2013.03.007. Epub 2013 Mar 28.

DOI:10.1016/j.yrtph.2013.03.007
PMID:23542091
Abstract

Chronic use at high dose of illicit drugs, alcohol and tobacco is associated with physical disease. The relative physical harm of these substances has not been described before, but will benefit the guiding of policy measures about licit and illicit substances. The physical harm of 19 addictive substances (including alcohol and tobacco), consisting of toxicity and the risk and severity of somatic disease (not psychiatric disease) was assessed based on literature data and the professional opinion of experts using scores ranging from 0 (no physical harm) to 3 (very serious physical harm). For alcohol, tobacco and some illicit drugs strong associations between long-term use or use in high dose versus the risk of somatic disease have been described, whereas for other substances such data are not available. Magic mushrooms, LSD and methylphenidate obtained relatively low scores (0.45-0.65) for physical harm, whereas relatively high scores were given for heroin (2.09), crack (2.32), alcohol (2.13) and tobacco (2.10). For cannabis, tobacco, and alcohol the estimated societal disease burden was higher than at individual level. The present ranking solely based on their physical harm was very similar to a previous ranking based on a combination of dependence liability, physical harm and social impairments.

摘要

长期大剂量使用非法药物、酒精和烟草会导致身体疾病。这些物质的相对身体危害以前没有被描述过,但将有助于指导关于合法和非法物质的政策措施。根据文献数据和专家的专业意见,对 19 种成瘾物质(包括酒精和烟草)的身体危害(不包括精神疾病)进行了评估,这些物质的毒性以及躯体疾病(非精神疾病)的风险和严重程度的评分范围为 0(无身体危害)至 3(非常严重的身体危害)。对于酒精、烟草和一些非法药物,长期使用或大剂量使用与躯体疾病风险之间存在很强的关联,而对于其他物质,则没有相关数据。迷幻蘑菇、LSD 和哌甲酯的身体危害评分相对较低(0.45-0.65),而海洛因(2.09)、快克(2.32)、酒精(2.13)和烟草(2.10)的评分相对较高。对于大麻、烟草和酒精,估计的社会疾病负担高于个人水平。目前的排名仅基于它们的身体危害,与以前基于依赖 Liability、身体危害和社会障碍的综合排名非常相似。

相似文献

1
Physical harm due to chronic substance use.因长期物质滥用导致的身体伤害。
Regul Toxicol Pharmacol. 2013 Jun;66(1):83-7. doi: 10.1016/j.yrtph.2013.03.007. Epub 2013 Mar 28.
2
Epidemiology of substance use in a representative sample of 18-year-old males.18岁男性代表性样本中的物质使用流行病学
Alcohol Alcohol. 2006 Mar-Apr;41(2):188-92. doi: 10.1093/alcalc/agh251. Epub 2005 Dec 1.
3
A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs.酒精、烟草及非法药物危害减少策略的疗效与效果综述
Drug Alcohol Rev. 2006 Nov;25(6):611-24. doi: 10.1080/09595230600944529.
4
Perceived risk associated with tobacco, alcohol and cannabis use among people with and without psychotic disorders.有和无精神病障碍者的烟草、酒精和大麻使用相关的感知风险。
Addict Behav. 2013 Jun;38(6):2246-51. doi: 10.1016/j.addbeh.2013.02.003. Epub 2013 Feb 18.
5
Charting WHO--goals for licit and illicit drugs for the year 2000: are we 'on track'?绘制世界卫生组织——2000年合法与非法药物目标:我们“步入正轨”了吗?
Public Health. 1997 Sep;111(5):271-5. doi: 10.1038/sj.ph.1900391.
6
The clinical content of preconception care: alcohol, tobacco, and illicit drug exposures.孕前保健的临床内容:酒精、烟草和非法药物暴露
Am J Obstet Gynecol. 2008 Dec;199(6 Suppl 2):S333-9. doi: 10.1016/j.ajog.2008.09.018.
7
Ranking the harm of alcohol, tobacco and illicit drugs for the individual and the population.对个人和人群而言,酒精、烟草和非法药物的危害程度排序。
Eur Addict Res. 2010;16(4):202-7. doi: 10.1159/000317249. Epub 2010 Jul 2.
8
Global burden of disease from alcohol, illicit drugs and tobacco.酒精、非法药物和烟草造成的全球疾病负担。
Drug Alcohol Rev. 2006 Nov;25(6):503-13. doi: 10.1080/09595230600944453.
9
Concurrent and simultaneous polydrug use among young Swiss males: use patterns and associations of number of substances used with health issues.瑞士年轻男性中同时并发的多种药物使用情况:使用模式以及使用药物种类数量与健康问题的关联
Int J Adolesc Med Health. 2014;26(2):217-24. doi: 10.1515/ijamh-2013-0305.
10
Mental health and alcohol, drugs and tobacco: a review of the comorbidity between mental disorders and the use of alcohol, tobacco and illicit drugs.心理健康与酒精、毒品和烟草:精神障碍与酒精、烟草及非法药物使用之间的共病关系综述
Drug Alcohol Rev. 2006 Nov;25(6):515-36. doi: 10.1080/09595230600944461.

引用本文的文献

1
What do patients with substance use disorders know about their medication? A cross-sectional interview-based study.患有物质使用障碍的患者对其药物了解多少?一项基于访谈的横断面研究。
Front Psychiatry. 2025 Apr 10;16:1556920. doi: 10.3389/fpsyt.2025.1556920. eCollection 2025.
2
Cardiovascular effects and safety of classic psychedelics.经典致幻剂的心血管效应与安全性
Nat Cardiovasc Res. 2025 Feb;4(2):131-144. doi: 10.1038/s44161-025-00608-2. Epub 2025 Feb 5.
3
The Use of Psychedelics in the Treatment of Medical Conditions: An Analysis of Currently Registered Psychedelics Studies in the American Drug Trial Registry.
迷幻药在医疗中的应用:对美国药物试验注册中心当前已注册的迷幻药研究的分析
Cureus. 2022 Sep 14;14(9):e29167. doi: 10.7759/cureus.29167. eCollection 2022 Sep.
4
Risk of somatic diseases in patients with eating disorders: the role of comorbid substance use disorders.进食障碍患者躯体疾病的风险:共病物质使用障碍的作用。
Epidemiol Psychiatr Sci. 2022 Oct 17;31:e73. doi: 10.1017/S204579602200052X.
5
Therapeutic Effects of Cannabidiol on Methamphetamine Abuse: A Review of Preclinical Study.大麻二酚对甲基苯丙胺滥用的治疗作用:临床前研究综述
Iran J Pharm Res. 2021 Fall;20(4):152-164. doi: 10.22037/ijpr.2021.114918.15106.
6
Eating disorders and subsequent risk of substance use disorders involving illicit drugs: a Danish nationwide register-based cohort study.进食障碍与随后涉及非法药物的物质使用障碍风险:一项丹麦全国基于登记的队列研究。
Soc Psychiatry Psychiatr Epidemiol. 2022 Apr;57(4):695-708. doi: 10.1007/s00127-021-02201-x. Epub 2022 Jan 5.
7
Frequencies of emergency department use and hospitalization comparing patients with different types of substance or polysubstance-related disorders.比较不同类型物质或多物质相关障碍患者的急诊使用频率和住院率。
Subst Abuse Treat Prev Policy. 2021 Dec 18;16(1):89. doi: 10.1186/s13011-021-00421-7.
8
Therapeutic Use of LSD in Psychiatry: A Systematic Review of Randomized-Controlled Clinical Trials.LSD在精神病学中的治疗应用:随机对照临床试验的系统评价
Front Psychiatry. 2020 Jan 21;10:943. doi: 10.3389/fpsyt.2019.00943. eCollection 2019.
9
Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies.阿亚瓦斯卡、二甲基色胺与精神病:对人体研究的系统评价
Ther Adv Psychopharmacol. 2017 Apr;7(4):141-157. doi: 10.1177/2045125316689030. Epub 2017 Feb 23.
10
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years.死藤水、裸盖菇素和麦角酸二乙酰胺(LSD)的抗抑郁、抗焦虑和抗成瘾作用:对过去25年发表的临床试验的系统评价
Ther Adv Psychopharmacol. 2016 Jun;6(3):193-213. doi: 10.1177/2045125316638008. Epub 2016 Mar 18.